Latest NAV & returns of NIPPON INDIA PRIVATE LTD.

Nippon India Pharma Fund - Bonus

Add To Compare

previously known as Reliance Pharma Bns until

NAV on June 12, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 8,636 cr
Turnover Ratio 14.27%
Expense Ratio 1.52%
Exit Load 1.00%if redeemed within
1 Months
0.00%if redeemed after 1 Months
Returns
  • 1M: 1.49%
  • 1Y: 4.65%
  • 3M: 5.14%
  • 3Y: 22.21%
  • 6M: 5.06%
  • 5Y: 12.34%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Sailesh Raj Bhan (Since about 21 years) Kinjal Desai (Since about 8 years) Amber Singhania (Since 3 months)
ISIN INF204K01950
Fund Family Nippon
P/E Ratio 36.71
P/B Ratio 5.41
Launch Date June 05, 2004
Benchmark BSE Healthcare TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs BSE Healthcare TR INR

Alpha -1.37
Beta 0.90
R-Squared 94.83
Info Ratio -0.93
Tracking Err 3.96
Sortino 1.711
Sharpe 0.977
Std Dev 15.782
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.0%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 100.00%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

View Factsheet

-
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
47.747 13.29% 2,939 cr 0.44% -
545.626 11.79% 4,566 cr 0.92% -
355.960 10.95% 1,217 cr 1.36% -
45.090 6.27% 6,454 cr 0.86% -


Other plans of Nippon India Pharma


Other Equity funds by Nippon